Conformationally adaptive therapeutic peptides for diseases caused by intrinsically disordered proteins (IDPs). New paradigm for drug discovery: Target the target, not the arrow
Pharmacology & Therapeutics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 108797 - 108797
Published: Jan. 1, 2025
The
traditional
model
of
protein
structure
determined
by
the
amino
acid
sequence
is
today
seriously
challenged
fact
that
approximately
half
human
proteome
made
up
proteins
do
not
have
a
stable
3D
structure,
either
partially
or
in
totality.
These
proteins,
called
intrinsically
disordered
(IDPs),
are
involved
numerous
physiological
functions
and
associated
with
severe
pathologies,
e.g.
Alzheimer,
Parkinson,
Creutzfeldt-Jakob,
amyotrophic
lateral
sclerosis
(ALS),
type
2
diabetes.
Targeting
these
challenging
for
two
reasons:
i)
we
need
to
preserve
their
functions,
ii)
drug
design
molecular
docking
possible
due
lack
reliable
starting
conditions.
Faced
this
challenge,
solutions
proposed
artificial
intelligence
(AI)
such
as
AlphaFold
clearly
unsuitable.
Instead,
suggest
an
innovative
approach
consisting
mimicking,
short
synthetic
peptides,
conformational
flexibility
IDPs.
which
call
adaptive
derived
from
domains
IDPs
become
structured
after
interacting
ligand.
Adaptive
peptides
designed
aim
selectively
antagonizing
harmful
effects
IDPs,
without
targeting
them
directly
but
through
selected
ligands,
affecting
properties.
This"target
target,
arrow"
strategy
promised
open
new
route
discovery
currently
undruggable
proteins.
Language: Английский
Cholesterol-Dependent Serotonin Insertion Controlled by Gangliosides in Model Lipid Membranes
Jacques Fantini,
No information about this author
Fodil Azzaz,
No information about this author
Ryad Bennaï
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(18), P. 10194 - 10194
Published: Sept. 23, 2024
Serotonin
is
distinct
among
synaptic
neurotransmitters
because
it
amphipathic
and
released
from
vesicles
at
concentrations
superior
to
its
water
solubility
limit
(270
mM
in
for
a
of
110
mM).
Hence,
serotonin
mostly
aggregated
the
cleft,
due
extensive
aromatic
stacking.
This
important
characteristic
has
received
scant
attention,
as
most
representations
serotonergic
synapse
take
warranted
that
molecules
are
present
monomers
after
vesicle
exocytosis.
Using
combination
silico
physicochemical
approaches
new
experimental
device
mimicking
conditions,
we
show
aggregates
efficiently
dissolved
by
gangliosides
(especially
GM1)
postsynaptic
membranes.
initial
interaction,
driven
electrostatic
forces,
attracts
insoluble
resolves
micelles
into
monomers.
also
interacts
with
cholesterol
via
set
CH-π
van
der
Waals
interactions.
Thus,
act
together
functional
serotonin-collecting
funnel
on
brain
cell
Based
this
unique
mode
interaction
membranes,
propose
model
transmission
takes
account
post-exocytosis
solubilizing
effect
aggregates.
Language: Английский
Characterization and Fluctuations of an Ivermectin Binding Site at the Lipid Raft Interface of the N-Terminal Domain (NTD) of the Spike Protein of SARS-CoV-2 Variants
Viruses,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1836 - 1836
Published: Nov. 27, 2024
Most
studies
on
the
docking
of
ivermectin
spike
protein
SARS-CoV-2
concern
receptor
binding
domain
(RBD)
and,
more
precisely,
RBD
interface
recognized
by
ACE2
receptor.
The
N-terminal
(NTD),
which
controls
initial
attachment
virus
to
lipid
raft
gangliosides,
has
not
received
attention
it
deserves.
In
this
study,
we
combined
molecular
modeling
and
physicochemical
approaches
analyze
mode
interaction
with
NTD-facing
rafts
host
cell
membrane.
We
characterize
a
area
that
presents
point
mutations
deletions
in
successive
variants
from
strain
omicron
KP.3
circulating
many
countries
2024.
show
exceptional
flexibility,
allowing
drug
bind
all
tested.
energy
is
specific
each
variant,
classification
according
their
affinity
for
following
ascending
order:
Omicron
<
Delta
BA.5
Alpha
Wuhan
(B.1)
BA.1.
site
subject
important
variations
NTD,
including
Y144
deletion.
It
overlaps
ganglioside
as
demonstrated
studies.
These
results
suggest
new
mechanism
antiviral
action
based
competitive
inhibition
rafts.
current
variant
still
ivermectin,
although
an
slightly
lower
than
strain.
Language: Английский